Engineers Gate Manager LP Ocugen, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $36,405 - $64,489	-20,803 Reduced 50.76%	20,182 $36,000
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $75,002 - $141,398	40,985 New	40,985 $93,000
Q1 2022 May 16, 2022	SELL	$2.34 - $4.72 $193,092 - $389,484	-82,518 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $361,428 - $1.29 Million	82,518 New	82,518 $375,000
Q3 2021 Nov 15, 2021	SELL	$6.36 - $8.51 $243,409 - $325,694	-38,272 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $211,261 - $600,104	38,272 New	38,272 $307,000

124

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $167M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.